Skip to main content
Premium Trial:

Request an Annual Quote

Gene Security Network Reels in $4M in VC Funding

NEW YORK (GenomeWeb News) - Molecular diagnostics company Gene Security Network has raised around $4 million in Series A financing, the firm said yesterday.
 
The round of venture funding was led by Claremont Creek Ventures and included investments from Sequoia Capital, Huntington Reproductive Center, and private investor Marissa Mayer, who is VP of search products and user experience at Google, with a focus on Google Health.
 
GSN plans to use the funds to commercialize its genetic screening technology, called Parental Support, which enables genetic tests for multiple diseases from a single cell and is being clinically tested for pre-implantation genetic diagnosis during in vitro fertilization.
 
The company said it expects its service to become available at IVF centers in the US in 2008.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.